Who We Are

Delivering on our promise for patients

Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

We are led by an experienced international management team. Our proprietary product pipeline and next-generation antibody technologies are the result of our strong company culture and a deep passion for innovation. We are inspired by nature and the power of the immune system to transform cancer treatment.

Button

Office Locations

We are a leading international biotech with a global footprint

Built on a foundation of science, innovation and drug discovery and development, we have offices and research centers where we collaborate to transform the way cancer is treated.

We employ approximately 600 people globally, including at our headquarters in Denmark and core facilities in the Netherlands and the United States. In addition, we have a regional office in Japan.


Genmab A/S

Kalvebod Brygge 43
1560 Copenhagen V
Denmark

Phone +45 7020 2728

CVR no. 2102 3884
LEI Code 529900MTJPDPE4MHJ122


Genmab B.V.

Visiting Address
Uppsalalaan 15
3584 CT Utrecht
The Netherlands

Postal Address
P.O. Box 85199
3508 AD Utrecht
The Netherlands

Phone +31 30 2 123 123

CVR Utrecht 30169902
VAT no. NL8095.75.000.B.01


Genmab U.S., Inc.

777 Scudders Mill Road
Plainsboro, NJ 08536
USA

Phone +1 609 430 2481


Genmab K.K.

Level 21 Shiodome Shibarikyu Building
1-2-3 Kaigan, Minato-ku
Tokyo 105-0022
Japan

Phone +81 3 5403 6330

Chamber of Commerce no.: 0104-01-14036



Contact us

Have a general inquiry?



Contact us for medical information and queries about a specific compound or program or how to participate in a clinical trial.


Rest assured, we will handle your personal data in accordance with our Privacy Policy.

  • Join our mission

    Be a part of our team and help transform the future of cancer treatment

    Learn more

  • Putting our expertise to work

    See how we put our in-depth knowledge of antibody biology into action

    Learn about our science

  • News, events and more

    Get the latest stock information and news about Genmab

    Learn more

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.